Radiology, Vol 140, 51-58, Copyright © 1981 by Radiological Society of North America

ARTICLES

Hepatic artery embolization in the treatment of hepatic neoplasms

VP Chuang and S Wallace

Seventy-two hepatic artery embolizations were performed in 47 patients to treat hepatic neoplasms. Hepatic artery embolization creates tumor devascularization, but the portal flow prevents infarction of liver parenchyma because of the single vascular supply from the hepatic artery to a neoplasm, in contrast to the dual vascular supply to the liver parenchyma. Indications for the use of hepatic artery embolization are failure of chemotherapy, either systemic or intra- arterial infusion, vascular anomalies requiring combined lobar embolization and lobar infusion, and lack of effective treatment. Three types of embolization were performed: peripheral embolization using Gelfoam, proximal embolization using coils, and combined peripheral and proximal embolization. The complications after embolization were pain, fever, and transient liver function changes. No death or hepatic abscess occurred. The median survival duration of the group was 11.5 months from the time of embolization. Hepatic artery embolization is an effective treatment of hepatic neoplasm.

This article has been cited by other articles:

				Y.-C. Lin, J.-H. Chen, K.-W. Han, and W.-C. Shen Ablation of Liver Tumor by Injection of Hypertonic Saline Am. J. Roentgenol., January 1, 2005; 184(1): 212 - 219. [Abstract] [Full Text] [PDF]

				K.-H. Lee, K.-B. Sung, D.-Y. Lee, S. J. Park, K. W. Kim, and J.-S. Yu Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Anatomic and Hemodynamic Considerations in the Hepatic Artery and Portal Vein RadioGraphics, September 1, 2002; 22(5): 1077 - 1091. [Abstract] [Full Text] [PDF]

				J. P. McGahan and G. D. Dodd III Radiofrequency Ablation of the Liver: Current Status Am. J. Roentgenol., January 1, 2001; 176(1): 3 - 16. [Full Text]

				T. Tancredi, P. A. McCuskey, Z. Kan, and S. Wallace Changes in Rat Liver Microcirculation after Experimental Hepatic Arterial Embolization: Comparison of Different Embolic Agents Radiology, April 1, 1999; 211(1): 177 - 181. [Abstract] [Full Text]

				I. Huk, P. Entscheff, M. Prager, F. Schulz, P. Polterauer, and J. Funovics Patency Rate of Implantable Devices During Long-Term Intraaterial Chemotherapy Angiology, November 1, 1990; 41(11): 936 - 941. [Abstract] [PDF]

				K.-S. Jeng and H.-J. Chiang Delayed Formation of Gallstones After Transcatheter Arterial Embolization for Hepatocellular Carcinoma: Is Elective Cholecystectomy Advisable During Hepatectomy? Arch Surg, November 1, 1989; 124(11): 1319 - 1322. [Abstract] [PDF]

				T.-L. Hwang, M.-F. chen, T.-Y. Lee, T.-J. chen, D.-Y. Lin, and Y.-F. Liaw Resection of Hepatocellular Carcinoma After Transcatheter Arterial Embolization: Reevaluation of the Advantages and Disadvantages of Preoperative Embolization Arch Surg, July 1, 1987; 122(7): 756 - 759. [Abstract] [PDF]